UB23:LSE:LSE-UBS MSCI Canada UCITS CAD A-dis (GBX)

ETF | Others |

Last Closing

USD 3506

Change

-3.00 (-0.09)%

Market Cap

N/A

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

-414.00 (-2.04%)

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

-2.54 (-0.97%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

-12.20 (-6.34%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.62 (-3.49%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

-0.64 (-4.67%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

-6.49 (-5.96%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+1.85 (+2.57%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

-1.02 (-3.41%)

USD 259.48B
0QZO:LSE 0QZO

-6.35 (-6.50%)

USD 258.54B

ETFs Containing UB23:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.92% 36% F 44% F
Dividend Return 0.01% 30% F 29% F
Total Return -1.90% 35% F 43% F
Trailing 12 Months  
Capital Gain 4.89% 56% F 59% D-
Dividend Return 0.02% 18% F 14% F
Total Return 4.92% 52% F 56% F
Trailing 5 Years  
Capital Gain 82.60% 62% D 69% C-
Dividend Return 0.18% 24% F 31% F
Total Return 82.78% 59% D- 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 9.91% 62% D 66% D+
Dividend Return 9.91% 61% D- 65% D
Total Return 0.00% 11% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 12.37% 55% F 73% C
Risk Adjusted Return 80.16% 77% C+ 86% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.